日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Determinants of response and molecular dynamics in HER2+ER+ breast cancers from the NA-PHER2 trial receiving HER2-targeted and endocrine therapies

NA-PHER2 试验中接受 HER2 靶向和内分泌治疗的 HER2+ER+ 乳腺癌的疗效和分子动力学决定因素

Maurizio Callari, Matteo Dugo, Marco Barreca, Balázs Győrffy, Barbara Galbardi, Lucia Vigano, Alberta Locatelli, Chiara Dall'Ara, Marina Ferrarini, Giancarlo Bisagni, Marco Colleoni, Mauro Mansutti, Claudio Zamagni, Lucia Del Mastro, Stefania Zambelli, Antonio Frassoldati, Olivia Biasi, Lajos Puszta

Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer: Long-Term Follow-Up of the Combined TEXT and SOFT Trials

绝经前乳腺癌辅助依西美坦联合卵巢抑制治疗:TEXT 和 SOFT 联合试验的长期随访

Olivia Pagani, Barbara A Walley, Gini F Fleming, Marco Colleoni, István Láng, Henry L Gomez, Carlo Tondini, Harold J Burstein, Matthew P Goetz, Eva M Ciruelos, Vered Stearns, Hervé R Bonnefoi, Silvana Martino, Charles E Geyer Jr, Claudio Chini, Fabio Puglisi, Simon Spazzapan, Thomas Ruhstaller, Eric

Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents

快速化疗诱导的急性内皮祖细胞动员:抗血管生成药物作为化学增敏剂的意义

Yuval Shaked, Erik Henke, Jeanine M L Roodhart, Patrizia Mancuso, Marlies H G Langenberg, Marco Colleoni, Laura G Daenen, Shan Man, Ping Xu, Urban Emmenegger, Terence Tang, Zhenping Zhu, Larry Witte, Robert M Strieter, Francesco Bertolini, Emile E Voest, Robert Benezra, Robert S Kerbel